Is LianBio (LIANY) a Buy, Sell, or Hold?
OTC : LIANY
LianBio — Institutional Ownership
$0.039 USD
-$0.01 (-13.33%)
- Volume
- 79.39K
- Average Volume
- 14.84K
- Market Capitalization
- $4.26M
- P/E Ratio
- 0.87
- Dividend Yield
- 1102.56%
- Price Target
- Year High
- $0.18
- Year Low
- $0.04
- Day High
- —
- Day Low
- —
- Payout Ratio
- $9.65
- Current Ratio
- $1466.01
Institutional Ownership Summary
Institutional Ownership %
%
Investors Holding
change: 0.0 | last:
Increased Positions
change: 0.0 | last:
Reduced Positions
change: 0.0 | last:
New Positions
change: 0.0 | last:
Sold Positions
change: 0.0 | last:
Total Calls
-
Total Puts
-
Put-Call Ratio
change: 0.0 | last:
Total Invested
-
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2023-11-30 | TANG CAPITAL PARTNERS, LP | 9.32M | 8.60% |
| 2023-11-30 | TANG CAPITAL MANAGEMENT, LLC | 9.32M | 8.60% |
| 2023-11-30 | KEVIN TANG | 9.32M | 8.60% |
| 2023-11-30 | Biosciences, LLC | - | 0.00% |
| 2021-11-15 | RA Capital Healthcare Fund, L.P. | 6.17M | 5.90% |
| 2021-11-15 | RA Capital Management, L.P. | 7.66M | 7.30% |
| 2021-11-15 | Peter Kolchinsky | 7.66M | 7.30% |
| 2021-11-15 | Rajeev Shah | 7.66M | 7.30% |
| 2021-11-10 | Venrock Healthcare Capital Partners III, L.P. | 5.38M | 5.10% |
| 2021-11-10 | Koh, Bong | 5.38M | 5.10% |
| 2021-11-10 | VHCP Management II, LLC | 5.38M | 5.10% |
| 2021-11-10 | VHCP Co-Investment Holdings III, LLC | 5.38M | 5.10% |
| 2021-11-10 | VHCP Management III, LLC | 5.38M | 5.10% |
| 2021-11-10 | Venrock Healthcare Capital Partners II, L.P. | 5.38M | 5.10% |
| 2021-11-10 | Venrock Healthcare Capital Partners EG, L.P. | 5.38M | 5.10% |
| 2021-11-10 | VHCP Co-Investment Holdings II, LLC | 5.38M | 5.10% |
| 2021-11-10 | VHCP Management EG, LLC | 5.38M | 5.10% |
| 2021-11-10 | Shah, Nimish | 5.38M | 5.10% |
LIANY Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $0.10 | 109.13M | $10.37M | $9.39M | -$ | $980.95K |
| 2024-12-31 | $0.27 | 108.28M | $28.69M | $51.7M | -$ | -$23.01M |
| 2023-12-31 | $4.47 | 107.92M | $482.4M | $438.58M | $2.46M | $46.28M |
| 2022-12-31 | $1.64 | 107.92M | $176.99M | $79.22M | $4.34M | $102.11M |
| 2021-12-31 | $6.16 | 107.28M | $660.81M | $228.18M | $4.83M | $437.47M |
| 2020-12-31 | $13.70 | 105.26M | $1.44B | $254.35M | $1.88M | $1.19B |
| 2019-12-31 | $13.70 | 108.3M | $1.48B | $43.3M | $532K | $1.44B |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2023-12-31 | $4.47 | 107.78M | $481.78M | $438.58M | $2.46M | $45.65M |
| 2023-09-30 | $1.49 | 107.17M | $159.68M | $103.46M | $2.84M | $59.07M |
| 2023-06-30 | $2.28 | 107.16M | $244.33M | $104.06M | $3.3M | $143.58M |
| 2023-03-31 | $1.96 | 107.16M | $210.04M | $102.33M | $3.92M | $111.62M |
| 2022-12-31 | $1.64 | 108.13M | $177.33M | $79.22M | $4.34M | $102.45M |
| 2022-09-30 | $2.00 | 108.35M | $216.71M | $78.86M | $4.77M | $142.61M |
| 2022-06-30 | $2.16 | 107.92M | $233.11M | $134.33M | $5.46M | $104.24M |
| 2022-03-31 | $3.71 | 107.28M | $397.99M | $139.86M | $4.72M | $262.85M |
| 2021-12-31 | $6.16 | 107.28M | $660.81M | $228.18M | $4.83M | $437.47M |
| 2021-09-30 | $13.70 | 108.3M | $1.48B | $109.02M | $306K | $1.38B |
| 2021-06-30 | $13.70 | 105.26M | $1.44B | -$ | -$ | $1.44B |
| 2021-03-31 | $13.70 | 105.26M | $1.44B | -$ | -$ | $1.44B |